See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2021_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 545,741,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,326,000 |
| 3 | remainder_Assets | 28,422,000 |
| 4 | LiabilitiesCurrent | 179,076,000 |
| 5 | LiabilitiesNoncurrent | 568,266,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 9,287,764 |
| 8 | SellingGeneralAndAdministrativeExpense | 342,375,237 |
| 9 | ResearchAndDevelopmentExpense | 180,255,674 |
| 10 | remainder_Expenses | 14,630,000 |
| 11 | remainder_Revenues | 480,377,304 |
| 12 | remainder_NetIncome | -50,640,369 |
| 13 | remainder_ComprehensiveNetIncome | 1,118,940 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 580,489,000 |
| 1 | Liabilities | 747,342,000 |
| 2 | Expenses | 546,548,675 |
| 3 | Revenues | 480,377,304 |
| 4 | StockholdersEquity | -166,853,000 |
| 5 | NetIncome | -116,811,740 |
| 6 | ComprehensiveNetIncome | -116,252,270 |
| 7 | BaseVar | 1,203,258,144 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.723 |
| 9 | EconomicCapitalRatio | 1.35 |